Company Profile

Momenta Pharmaceuticals Inc (AKA: Mimeon Inc)
Profile last edited on: 11/13/2023      CAGE: 66BQ6      UEI: QG1GG1RGN1T6

Business Identifier: Characterization and process engineering of complex molecules: treatments for rare immune-mediated diseases
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

675 West Kendall Street
Cambridge, MA 02142
   (617) 491-9700
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

In June 2020 it was announced that J&J would buy Momenta Pharmaceuticals (NASDAQ:MNTA) for $6.5B. Originally based on technology developed at, and licensed from, Massachusetts Institute of Technology (MIT), Momenta Pharmaceuticals, Inc. - initially doing business as Mineion, Inc., is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, novel drugs, and the discovery of new biological processes. SBIR-involved on a very limited basis in its early years, based on the firm's understanding of sugars Momenta has developed a diversified pipeline of novel discovery and development candidates and near-term product opportunities. By enabling detailed chemical and structural analysis of complex sugars, the firm's technology provides a more complete understanding of the roles that sugars play in cellular function, disease, and drug action.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 1 NIH $100,000
Project Title: Glycoprofiling PSA for Prostate Cancer Diagnosis

Key People / Management

  Craig A Wheeler -- President & Chief Executive Officer

  John E Bishop -- Vice President, Pharmaceutical Sciences & Manufacturing

  Steven B Brugger -- Senior Vice President, Strategic Business Operations

  Alan L Crane -- Former President

  Ian D Fier -- Vice President, Development Operations

  Barbara Rosengren -- Vice President, Strategic Product Development

  Ram Sasisekharan -- Co-Founder

  Richard P Shea -- CFO

  Zachary H Shriver

  Mallik Sundaram -- Co-Founder

  Ganesh Venkataraman -- Founder & VP, Technology

  Christoph Westphal -- Co-Founder

  Susan K Whoriskey -- Vice President, Licensing and Business Development

Company News